Organisation
Department of Pharmaceutics
Department
Current researchers
21 - 30 of 120 results
- Goedele Craye (Member)
- Simon Daled (Member)
- Kaat De Clerck (Member)
- Laura De Clerck (Member)
- Chloë De Clercq (Member)
- Ruben De Coen (Member)
- Emma De Coster (Member)
- Bruno De Geest (Member)
- Dominic De Groote (Member)
- Herlinde De Keersmaecker (Member)
Projects
21 - 30 of 375
- Evaluation of a new treatment against "blackhead" disease in turkeys (POULTRY 2)From16 Oct 2023 → TodayFunding: IOF - technology validation in lab
- Exploring co-encapsulation of antihistamines and immune checkpoint siRNAs in lipid nanoparticles for cancer immunotherapy.From1 Oct 2023 → TodayFunding: BOF - doctoral mandates
- Engineering of universal iPSC-derived therapeutic cells by nanofiber photoporation.From1 Oct 2023 → 31 Oct 2023Funding: BOF - doctoral mandates
- HEPTAMETHINE CYANINE-POLY(ETHYLENE GLYCOL) AS MOLECULAR ANCHOR FOR TUMOR TARGETED CYTOKINE DELIVERYFrom1 Oct 2023 → TodayFunding: FWO senior postdoctoral fellowship
- Uncovering the mechanism underlying and consequences of alphaherpesvirus-induced formation of tunneling nanotubes (TNTs)From1 Oct 2023 → TodayFunding: BOF - doctoral mandates
- Cofunding core facility - NMR Expertise CentreFrom1 Oct 2023 → TodayFunding: BOF - research organisations
- Characterisation of an obese piglet model to study drug dosing in obese childrenFrom1 Oct 2023 → TodayFunding: BOF - projects
- MACYCs / Membrane Anchoring CYtokine ChimeraS: Unlocking the full potential of tumor acidity for tumor-targeted cytokine delivery.From1 Oct 2023 → TodayFunding: BOF - doctoral mandates
- Biological characterisation of novel plasmid-carrying avian Chlamydia abortus strain 84/2334, a vaccine candidate for enzootic abortion in sheepFrom1 Oct 2023 → TodayFunding: BOF - projects
- Novel Polymers for siRNA transfectionFrom1 Oct 2023 → TodayFunding: IOF - technology concept exploration
Publications
1 - 10 of 1921
- Tailored design of sugar-modified a-GalCer analogues for Th1-polarized immune responses(2018)
Authors: Serge Van Calenbergh
Pages: 42 - 42 - Structural basis for the recognition of C20:2-U+03B1GalCer by the invariant natural killer T-cell receptor-like antibody L363(2012)
Authors: Esther Dawen Yu, Enrico Girardi, Jing Wang, Thien-Thi Mac Mac, Karl OA Yu, Serge Van Calenbergh, Steven A Porcelli, Dirk M Zajonc
Pages: 1269 - 1278 - Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease(2014)
Authors: Maria Sabater-Lleal, Aners Mälarstig, Lasse Folkersen, María Soler Artigas, Damiano Baldassarre, Maryam Kavousi, Peter Almgren, Fabrizio Veglia, Guy Brusselle, Albert Hofman, et al.
- Outpatient Pharmacotherapy(2008)
Authors: Guy Brusselle
Pages: 331 - 349 - Properties of the COPD assessment test in a cross-sectional European study(2011)
Authors: PW Jones, Guy Brusselle, RW Dal Negro, M Ferrer, P Kardos, ML Levye, T Perez, JJ Soler Cataluña, T van der Molen, L Adamek, et al.
Pages: 29 - 35 - Mechanistic links between COPD and lung cancer: a role of microRNA let-7?(2014)
Authors: Jae Il Shin, Guy Brusselle
Pages: 70 - 70 - Effect of a 3-month low-dose azithromycin intervention for COPD exacerbations requiring hospitalization on subsequent respiratory events and mortality : the BACE trial(2019)Volume: 199
Authors: W Janssens, K Vermeersch, T Troosters, Guy Brusselle
Number of pages: 1 - Disease-modifying anti-asthmatic drugs(2022)
Authors: Marek Lommatzsch, Guy Brusselle, G. Walter Canonica, David J. Jackson, Parameswaran Nair, Roland Buhl, Johann Christian Virchow
Pages: 1664 - 1668 - I have taken my umbrella, so of course it does not rain(2012)
Authors: DS Postma, Guy Brusselle, A Bush, JW Holloway
Pages: 88 - 89 - Blood eosinophils and smoking history affect outcome with high dose N-acetylcysteine treatment in COPD(2017)Volume: 50
Authors: Alberto Papi, Guy Brusselle, Francesco Sergio, Marco Pannacci, Jinping Zheng, Gerard Criner
Number of pages: 1